Laryngeal squamous cell carcinoma (LSCC) is the most common type of head and neck malignancy.
NAT10 is a catalytic enzyme for ac4C and is involved in the progression of a variety of cancers.
This study aimed to explore the effects and potential mechanisms of NAT10 in LSCC.
